LSV Asset Management
JNP

LSV Asset Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

LSV Asset Management’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-66,573
Closed -$685K – 1055
2015
Q4 		$685K Sell
66,573
-3,500
-5% -$40.6K ﹤0.01% 790
2015
Q3 		$825K Sell
70,073
-15,600
-18% -$172K ﹤0.01% 743
2015
Q2 		$783K Hold
85,673
– – ﹤0.01% 748
2015
Q1 		$532K Buy
85,673
+17,273
+25% +$107K ﹤0.01% 749
2014
Q4 		$383K Buy
68,400
+6,295
+10% +$36.6K ﹤0.01% 780
2014
Q3 		$365K Buy
62,105
+58,005
+1,415% +$354K ﹤0.01% 773
2014
Q2 		$28K Buy
+4,100
New +$27.4K ﹤0.01% 853

Other funds holding JNP

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LSV Asset Management's JNP Position: Q1 2016 in Review

LSV Asset Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q1 2016, closing a stake of 66,573 shares — an estimated $685K sold.

LSV Asset Management first reported a position in JNP in Q2 2014 and held it in 7 quarters. The position peaked at $825K in Q3 2015. 50 funds tracked by Wall St. Rank hold JNP as of Q1 2016.

  • LSV Asset Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • LSV Asset Management sold 66,573 Juniper Pharmaceuticals, Inc. Common Stock shares in Q1 2016, an estimated $685K.
  • LSV Asset Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2014 and held it in 7 quarters.
  • LSV Asset Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $825K in Q3 2015.
  • 50 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q1 2016.

Based on LSV Asset Management's 13F filing for Q1 2016, filed 10 May 2016.